superDimension Ltd.
This article was originally published in Start Up
Executive Summary
superDimension describes its interventional pulmonology device as a"global positioning system" for the lungs. Based on electromagnetic localization technology, superDimension combines a novel, steerable catheter that can maneuver in the tiny vessels at the lungs' periphery, with image-processing and navigation technologies that allow pulmonologists to visualize in real time the path of the catheter as it moves through the lungs.
You may also be interested in...
Device CEOs Who Find The Funding
The financial world may be in crisis, but top-tier medical device companies can still raise capital. But at what price? Four medical device execs answer those questions and many more.
The Golden Age in Cancer Medtech Investing
Short of investing in the kinds of products that must demonstrate five-year survival rates, the field of cancer offers many near term investment opportunities, and large markets to support them. As noted in US Disease Incidence and Prevalence, a report recently published by the Medtech Insight division of FDC-Windhover, like many diseases, the incidence of cancer increases with age. More than 10.8 million people in the US have a history of cancer; and in 2008, at least 1.4 million more people will be diagnosed. According to the Medtech Insight report, breast cancer has the highest prevalence rate, followed by prostate and colorectal cancers.
Start-Up News November 2006
Advances in imaging technologies mean that tiny lung nodules can now be detected, creating a need for technologies for diagnosing and treating lung cancer at early stages. Median Technologies, in computer-assisted detection, PneumRx, with a better biopsy tool, and Perceptronix Medical and Menssana Research, with novel diagnostics, hope to help here.